They also inhibit the T-cell antitumour response that is responsible for the immune suppressive milieu in the tumour by increasing the VEGF (vascular endothelial growth factor) and TGF-β (transforming growth factor—beta) production [7]. This evidence concerns the gene VEGFA and neoplasm.